VEROVACCINES
VEROVACCiNES discovers and develops innovative vaccine solutions, to protect animals against infectious diseases. Key is a novel, broadly applicable, yeast-based technology to generate subunit marker vaccines. This technology has been validated by demonstrating protection of several target animal species against different viral diseases (proof-of-concept). VEROVACCiNES GmbH is a spin-off company of the Martin Luther University Halle-Wittenberg, Germany in 2017. The company exclusively took over... IP, brand, team, products and know-how from the former BMBF GO-Bio-funded VEROVACCiNES project at Halle University. VEROVACCiNES GmbH is eligible for follow-up phase 2 funding from the same BMBF GO-Bio program. They cooperate closely with veterinary pharmaceutical companies, universities and research institutes, and they are eager to initiate new collaborations.
VEROVACCINES
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2017-01-01
Address:
Halle, Niedersachsen, Germany
Country:
Germany
Website Url:
http://www.verovaccines.org
Total Employee:
11+
Status:
Active
Contact:
+49 345 5526309
Total Funding:
3.1 M EUR
Technology used in webpage:
SPF Apple Mobile Web Clips Icon IPv6 Microsoft Exchange Online Office 365 Mail IONOS 1and1
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
i2 Pharmaceuticals
i2 Pharmaceuticals, a biopharmaceutical company.
IntraBio
IntraBio is a biopharmaceutical company.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
Current Employees Featured
Founder
Investors List
German Federal Ministry of Education and Research
German Federal Ministry of Education and Research investment in Series B - Verovaccines
German Federal Ministry of Education and Research
German Federal Ministry of Education and Research investment in Seed Round - Verovaccines
Business Angels Switzerland (BAS)
Business Angels Switzerland (BAS) investment in Seed Round - Verovaccines
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Seed Round - Verovaccines
German Federal Ministry of Education and Research
German Federal Ministry of Education and Research investment in Grant - Verovaccines
Official Site Inspections
http://www.verovaccines.org
- Host name: 217-160-0-5.elastic-ssl.ui-r.com
- IP address: 217.160.0.5
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Verovaccines"
VEROVACCiNES GmbH
The team of VEROVACCiNES GmbH is built around talented researchers skilled in virology, molecular biology, veterinary medicine and process engineering. More. Funding & Partners. …See details»
Verovaccines - Crunchbase Company Profile & Funding
VEROVACCiNES GmbH is a spin-off company of the Martin Luther University Halle-Wittenberg, Germany in 2017. The company exclusively took over IP, brand, team, products and know-how from the former BMBF GO-Bio-funded …See details»
VEROVACCiNES GmbH - LinkedIn
VEROVACCiNES develops and markets a novel class of innovative, proprietary subunit marker vaccines for animal health. The technology provides a validated solution to the industry's need for - cost ...See details»
Verovaccines - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 14, 2021: Series B - …See details»
VEROVACCiNES (VEROVACCiNES GmbH)
Legal Entity: VEROVACCiNES GmbH Location: Sachsen-Anhalt Overview Company Funding Product Team News Is this your company? Profile is not claimed et. This profile is created by …See details»
VEROVACCiNES GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VEROVACCiNES GmbH of Halle (Saale), Sachsen-Anhalt. Get the latest business insights …See details»
VEROVACCiNES 2025 Company Profile: Valuation, …
VEROVACCiNES General Information Description. Developer of innovative vaccines designed to protect animals against infectious diseases for animal health. The company's proprietary vaccine platform enables optimized …See details»
Verovaccines - Contacts, Employees, Board Members, Advisors
Organization. Verovaccines . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Verovaccines …See details»
VEROVACCiNES GmbH - Halle (Saale), Germany - bionity.com
VEROVACCiNES is a German biopharmaceutical company. We discover and develop innovative vaccine solutions, to protect animals against infectious diseases. Key is a novel, broadly …See details»
Team - VeroVaccines GmbH
VEROVACCiNES GmbH Blücherstraße 26 06120 Halle (Saale) More about us. News & Events History Pipeline Innovation VEROVACCiNES GmbH Blücherstraße 26 06120 Halle (Saale), Germany. Telefon: +49 345 131428 …See details»
Vaccine developer Verovaccines GmbH concludes international …
Dec 3, 2019 Verovaccines GmbH is a spin-off of Prof. Dr. Sven-Erik Behrens, Dr. Hanjo Hennemann and Dr. Martina Behrens from the Martin Luther University Halle-Wittenberg, …See details»
History - VeroVaccines GmbH
Foundation Verovaccines GmbH. 12/2014. Hugo Junkers prize. 04/2014. Dr. Hennemann joins team. 2009. Start research on technology. News & Events Pipeline Innovation Team …See details»
Verovaccines - EU-Startups
VEROVACCiNES develops and markets a novel class of innovative, proprietary subunit marker vaccines for animal health. The technology provides a validated solution to the industry's need …See details»
More About Us | VeroVaccines GmbH
History VEROVACCiNES spun off Martin-Luther-University Halle-Wittenberg in 2017. After validating the novel technology platform (Proof of Concept in several vaccine programs), we …See details»
VEROVACCiNES secures a 7-digit financing to expand its vaccine …
Feb 27, 2025 The CSO of VEROVACCiNES, Prof. Sven-Erik Behrens, emphasizes the importance of the financing round: “With these funds, we can significantly accelerate our …See details»
Verovaccines - Crunchbase
Organization. Verovaccines . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
Small German start-up develops bluetongue virus vaccine within a …
Oct 9, 2024 The German vaccine specialist Verovaccines has shown how to go from a simple BTV-3 virus sequence to a validated vaccine in just a few months. In addition, an approval …See details»
Volume 31, Number 6—June 2025 - Centers for Disease Control …
Apr 3, 2025 One of the highest profile wildlife species known to be affected by HPAI in North America is the California condor (Gymnogyps californianus) (Figure 1, panel A).California …See details»
Verovaccines Reviews, Funding, Founder, Valuation & Jobs
VEROVACCiNES develops and markets a novel class of innovative, proprietary subunit marker vaccines for animal health. The technology provides a validated solution to the industry's need …See details»
VEROVACCiNES GmbH
Feb 25, 2025 Verovaccines develops the first recombinant subunit vaccine against the current bluetongue virus -3 (BTV-3) outbreak that impacts sheep and cattle in Europe; Using a new …See details»